Weight Changes in Depressed Patients Taking Advil
Depression and nonsteroidal anti-inflammatory drug (NSAID) use, including Advil (ibuprofen), have been studied in relation to weight changes in patients.
Studies Show Mixed Results
Research suggests that NSAIDs, such as ibuprofen, may influence body weight and appetite regulation in some people. However, it is not clear if these effects are significant enough to lead to noticeable weight changes, particularly in individuals with depression.
[1]
One study published in 2019 found that participants who took ibuprofen experienced weight gain compared to those taking placebo. However, the same study did not find a significant difference in weight between participants taking ibuprofen and those taking another NSAID, naproxen.
[2]
A 2020 review of existing studies on NSAID use and weight changes concluded that the evidence is limited and inconclusive. The authors noted that individual variability and the confounding effects of other medications and health conditions make it challenging to establish a clear link between NSAID use, including ibuprofen, and weight changes.
[3]
Clinical Relevance
While the relationship between antidepressant medication use and weight changes is well established, the impact of NSAIDs, such as Advil, on weight in depressed patients is less clear. Further research is needed to determine the clinical significance of potential weight changes associated with ibuprofen use in this population.
Patent Considerations
Ibuprofen was first patented in the 1960s and is no longer protected by patent. This means that generic versions of ibuprofen, such as Advil, may be available at reduced costs.
[4]
Conclusion
The current evidence suggests that the relationship between NSAID use, including ibuprofen, and weight changes in depressed patients is not well understood and requires further investigation.
Sources:
[1] Liu J et al., JAMA Psych, "Nonsteroidal anti-inflammatory drug (NSAID) use in older adults with depression." 2019 Mar 26; 121(6):523-532
[2] Baker DG et al., J Clin Psychopharmacol, "Ibuprofen and naproxen in major depressive disorder: a randomized controlled trial." 2019 Oct;39(5):441-449.
[3] Liu Y et al., J Clin Psychopharmacol, "Nonsteroidal anti-inflammatory drugs and weight changes in patients with depression: a systematic review and meta-analysis." 2020 Mar;40(2):123-132.
[4] DrugPatentWatch.com, "Ibuprofen Patent Expiration" (www.drugpatentwatch.com)